Emiliano Tamburini

7PUBLICATIONS
62CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 25, 2023
Primary Tumor Resection in Synchronous Metastatic Colorectal Cancer Patients Treated with Upfront Chemotherapy plus Bevacizumab: A Pooled Analysis of TRIBE and TRIBE2 Studies.

Valentina Fanotto, Daniele Rossini, Mariaelena Casagrande

|Jun 22, 2023
Impact of Oocyte Extract Supplement on Quality of Life after Hepatectomy for Liver Tumours: A Prospective, Multicentre, Double-Blind Randomized Clinical Trial.

Matteo Donadon, Angela Palmisano, Mariano Bizzarri

|Apr 06, 2023
An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer.

Carlotta Antoniotti, Alessandra Boccaccino, Robert Seitz

|Jun 06, 2022
Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With RAS/BRAF Wild-Type Metastatic Colorectal Cancer: The Phase III TRIPLETE Study by GONO.

Daniele Rossini, Carlotta Antoniotti, Sara Lonardi

|Jan 07, 2022
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy.

Valentina Burgio, Massimo Iavarone, Giovanni Giuseppe Di Costanzo

|Sep 01, 2021
Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic Implications.

Roberto Moretto, Andrew Elliott, Jian Zhang

Pageof 2

Frequent Collaborators

4 joint publications

Veronica Conca

3 joint publications

Chiara Cremolini

3 joint publications

Alessandro Passardi

3 joint publications

Filippo Pietrantonio